Author
Listed:
- Maria J. Gonzalez-Rellan
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn))
- Marcos F. Fondevila
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn))
- Uxia Fernandez
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn))
- Amaia Rodríguez
(CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn)
Metabolic Research Laboratory, Clínica Universidad de Navarra and IdiSNA)
- Marta Varela-Rey
(Bizkaia Technology Park
CIBERehd, Instituto de Salud Carlos III)
- Christelle Veyrat-Durebex
(University of Geneva
University of Geneva)
- Samuel Seoane
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Ganeko Bernardo
(Basque Research and Technology Alliance
ATLAS Molecular Pharma S. L.)
- Fernando Lopitz-Otsoa
(Basque Research and Technology Alliance)
- David Fernández-Ramos
(CIBERehd, Instituto de Salud Carlos III
Basque Research and Technology Alliance)
- Jon Bilbao
(Basque Research and Technology Alliance)
- Cristina Iglesias
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Eva Novoa
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Cristina Ameneiro
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Ana Senra
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Daniel Beiroa
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Juan Cuñarro
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Maria Chantada-Vazquez
(Santiago de Compostela)
- Maria Garcia-Vence
(Santiago de Compostela)
- Susana B. Bravo
(Santiago de Compostela)
- Natalia Da Silva Lima
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Begoña Porteiro
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Carmen Carneiro
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Anxo Vidal
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Sulay Tovar
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Timo D. Müller
(German Research Center for Environmental Health (GmbH) and German Center for Diabetes Research (DZD)
Institute of Experimental and Clinical Pharmacology and Pharmacogenomics, Eberhard Karls University Hospitals and Clinics)
- Johan Ferno
(Haukeland University Hospital)
- Diana Guallar
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Miguel Fidalgo
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Guadalupe Sabio
(Centro Nacional de Investigaciones Cardiovasculares (CNIC))
- Stephan Herzig
(Institute for Diabetes and Cancer (IDC) and Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich)
- Won Ho Yang
(Yonsei University)
- Jin Won Cho
(Yonsei University)
- Maria Luz Martinez-Chantar
(Bizkaia Technology Park)
- Roman Perez-Fernandez
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Miguel López
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Carlos Dieguez
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria)
- Jose M. Mato
(University of Geneva
University of Geneva
ATLAS Molecular Pharma S. L.)
- Oscar Millet
(University of Geneva
Basque Research and Technology Alliance)
- Roberto Coppari
(CIBERehd, Instituto de Salud Carlos III)
- Ashwin Woodhoo
(IKERBASQUE, Basque Foundation for Science
CIMUS, University of Santigo de Compostela-Instituto de Investigación Sanitaria
Bizkaia Technology Park
Galician Agency of Innovation (GAIN), Xunta de Galicia)
- Gema Fruhbeck
(CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn)
Metabolic Research Laboratory, Clínica Universidad de Navarra and IdiSNA)
- Ruben Nogueiras
(CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBERobn)
Galician Agency of Innovation (GAIN), Xunta de Galicia)
Abstract
p53 regulates several signaling pathways to maintain the metabolic homeostasis of cells and modulates the cellular response to stress. Deficiency or excess of nutrients causes cellular metabolic stress, and we hypothesized that p53 could be linked to glucose maintenance. We show here that upon starvation hepatic p53 is stabilized by O-GlcNAcylation and plays an essential role in the physiological regulation of glucose homeostasis. More specifically, p53 binds to PCK1 promoter and regulates its transcriptional activation, thereby controlling hepatic glucose production. Mice lacking p53 in the liver show a reduced gluconeogenic response during calorie restriction. Glucagon, adrenaline and glucocorticoids augment protein levels of p53, and administration of these hormones to p53 deficient human hepatocytes and to liver-specific p53 deficient mice fails to increase glucose levels. Moreover, insulin decreases p53 levels, and over-expression of p53 impairs insulin sensitivity. Finally, protein levels of p53, as well as genes responsible of O-GlcNAcylation are elevated in the liver of type 2 diabetic patients and positively correlate with glucose and HOMA-IR. Overall these results indicate that the O-GlcNAcylation of p53 plays an unsuspected key role regulating in vivo glucose homeostasis.
Suggested Citation
Maria J. Gonzalez-Rellan & Marcos F. Fondevila & Uxia Fernandez & Amaia Rodríguez & Marta Varela-Rey & Christelle Veyrat-Durebex & Samuel Seoane & Ganeko Bernardo & Fernando Lopitz-Otsoa & David Ferná, 2021.
"O-GlcNAcylated p53 in the liver modulates hepatic glucose production,"
Nature Communications, Nature, vol. 12(1), pages 1-21, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25390-0
DOI: 10.1038/s41467-021-25390-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25390-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.